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2 Introduction 
 
The provision of traceable standards to the biological community is an area of active 
research in many NMIs. The quantification of the relative amount of DNA sequences 
extracted from a biological tissue remains a complex analytical procedure and relies 
on the availability of such standards. Real-time PCR is currently the most applied 
measurement method to identify and quantify DNA sequences. Several NMIs were 
able to demonstrate their ability to use this technology to quantify a defined plasmid 
DNA using the same plasmid DNA as a calibrant (CCQM-P44 (1&2) and CCQM KC-
61). The same measurement method was used to quantify genomic DNA extracted 
from a plant tissue and calibrated by a genomic DNA solution extracted from the 
same plant material (CCQM-P60). In a later study, the importance of a reliable DNA 
extraction method became apparent. The analytical procedure was more complex in 
CCQM-P60 compared to KC61, as it included a DNA extraction step. However, both 
studies were performed using matching calibrants for which a reference value had 
been assigned. 
The goal of this pilot study was to demonstrate the ability to quantify DNA sequences 
present in a biological tissue using an independent calibration system. The 
quantification should ideally be performed by quantitative real-time PCR (QRT-PCR), 
but other methods not relying on the efficiency of thermal amplification such as digital 
PCR could also be applied. 
The methodology requires extraction and purification of genomic DNA and accurate 
detection and quantification of the relative amount of two defined DNA sequences in 
the extracted genomic DNA.  
 
3 Description of the Measurands 
 
Both samples to be analysed are maize powders each containing a low but different 
number of copies of the same defined DNA sequence. The estimated number of 
copies to be detected ranged from 20 to 2 000 00 copies.  
 
The ratio between the number of those two DNA sequences in the sample 1 and 2 
must be determined:  
 
Target sequence 1: (58 bp) 
CTTTgCCAAgATCAAgCggAgTgAgggCCTTgAgTTAggCCATTCTggCCgAAgACTA 
 
Target sequence 2: (79 bp) 
GCTACATAgggAgCCTTgTCCTACAATCCACACAAACgCACgCgTAAAACAATTAAT
CAgCACgAgATTTCTAgTCCAA 
 
The primer and probe sequences to be used for real-time PCR amplification are 
given in Annex 3. 
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4  Samples to be analysed 
 
4.1 Description 
 
Samples 1 and 3 were ERM-BF418b1 whereas samples 2 and 4 were ERM-BF418c2. 
Both CRMs are maize powders each containing a defined mass fraction of 
genetically modified (GM) 1507 maize3. The Certified Reference Materials (CRMs) 
were produced and certified under the responsibility of the IRMM and were prepared 
by mixing of dried non-GM maize powder and 1507 GM dried maize powder 
subsequently. The mass fraction was certified taking the respective purity and water 
mass fractions into account.  
 
4.2 Copy number ratio 
 
Samples 2 and 4 were additionally certified to contain a defined ratio of the two DNA 
sequences present in 1507 maize. The ERM®-BF418c contains 0.49 ± 0.14 % 1507 
copies per hmg copy. The certification is, however, on-going and the certified value 
not yet assigned. 
 
Sample 1:  was prepared gravimetrically and contains 
9.9
1
 of the mass fraction of 
sample 2 
 
Sample 2 : 0.49 ± 0.14  1507 copies/hmg copies [%] 
 
Sample 3 : is identical to sample 1 
 
Sample 4 : is identical to sample 2 
 
4.3 Stability 
 
The uncertainty contribution from the long-term stability was estimated by calculating 
the uncertainty on the mass fraction ratio of samples stored at 4 ºC and -70 ºC ( x 4 
ºC/ x -70 ºC), with -70 °C being the reference temperature at which the material is 
considered to be stable. Accepting a shelf life of 18 months before additional stability 
measurements are required, a standard uncertainty contribution for the stability (ults) 
of 0.054 % was calculated. It is recommended to store the bottles at 4 ºC. 
                                                 
1
 http://www.irmm.jrc.be/html/reference_materials_catalogue/catalogue/attachements/ERM-
BF418b_cert.pdf 
2
 http://www.irmm.jrc.be/html/reference_materials_catalogue/catalogue/attachements/ERM-
BF418c_cert.pdf 
3
 Also named Herculex I TC1507 corn 
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5 Calibrant used 
5.1 Description 
 
The calibrant to be used was a candidate CRM (ERM-AD418). IRMM has 
constructed this plasmid DNA (pIRMM-0069) and has investigated its suitability for 
the calibration of quantitative measurements of maize event 1507. ERM-AD418 was 
processed according to the ISO Guide 34, certification is still on-going. The plasmid 
CRM is intended to be certified for the number of DNA fragments per plasmid of a 
1507 transgenic sequence and of the high mobility group gene (hmg). The plasmid 
contains a 58 bp fragment of the transition region of the 35S-terminator into the 
ORF25 PolyA terminator and a 351 bp fragment of the maize endogenous hmg gene 
corresponding to the transition of the intron 4 into the exon 5 of the gene encoding 
the high mobility group protein A from Zea mays.  
 
ERM-AD418 was prepared by diluting the pIRMM-0069 in a background of ColE1 
plasmid DNA at a final concentration of 1 ng/µL. The buffer used for the dilution 
contained 1 mmol/L Tris, 0.01 mmol/L EDTA pH 8.0. 
 
After its release ERM-AD418 is intended to be used for the calibration of 1507 maize 
QRT-PCR method as described and validated by the Community Reference 
Laboratory for GM Food and Feed4. 
 
pIRMM-0069
3196 bps
Nde I
Pvu II
Hin dIII
Kpn I
Sac I
Bam HI
Spe I
Eco RI
Eco RI
Pst I
Eco RV
Not I
Sph I
Nsi I
Xba I
Bam HI
Sma I
Xma I
Kpn I
Sac I
Eco RI
Eco RI
Pvu II
ISca
lacZ
1507 trans
lacZ
hmg
lacZ
AP(R)
 
Figure 1: Circular map of pIRMM-0069 representing the 3'plant- junction and hmg 
inserts as well as the enzymatic restriction sites.  
 
                                                 
4
 http://gmo-crl.jrc.it/summaries/TC1507-WEB-Protocol-Validation.pdf 
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5.2 Purity of the calibrant 
 
The purity of the plasmid pIRMM-0069 was analysed by agarose gel electrophoresis 
and no other DNA bands than those expected after restriction of the pIRMM-0069 
with EcoRI (Fig 2. lane 2) and HindIII/XbaI (Fig 2.  lane 3) could be seen after 
ethidium bromide staining. This confirmed the correct cloning of the fragments.  
 
 
 
 
 
 
Figure 2: Restriction analysis of pIRMM-0069 
Lane 1: pIRMM-0069 uncut; Lane 2: restricted with EcoRI (expected fragments: 2683 
bp, 367 bp, 72bp, 74 bp); Lane 3: ERM-AD418 restricted with HindIII/XbaI (expected 
fragments: 3028 bp, 168 bp); M: molecular DNA marker (BioRad 50-2000 bp). White 
horizontal arrows indicate the positions of smaller fragments. The fragments sized 72 
and 74 bp could not be discriminated under the electrophoresis conditions applied 
here. 
 
 
As no smear was visible after restriction with EcoRI restriction enzyme of the plasmid 
preparation and no RNA band was visible, it can be reasonably concluded that the 
plasmid preparation was not contaminated with external genomic DNA or a relatively 
large amount of RNA molecules. However, traces of genomic DNA from host 
bacterial cell or traces of RNA molecules can not be excluded in the final plasmid 
preparation. 
Such traces do not influence the target sequence ratio. Indeed a BLASTN 2.2.18 
analysis of the cloned target sequences did not reveal any nucleic acid sequences 
identity with bacterial genomic DNA sources from the NCBI databases (data not 
shown). 
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Additionally, remaining traces of E. coli genomic DNA or RNA would not affect the 
measurement as the primers and probe used are highly specific for the targeted 
sequence and do not hybridise to other DNA fragments that could be present in the 
final preparation. Such traces may represent, however, a bias in the DNA 
quantification of the plasmid solution by UV and therefore an erroneous estimation of 
the number of plasmid copies in the tube. For that reason the DNA concentration in 
each tube can only be given as an approximate value. 
 
Despite the fact that the enzymatic restriction conditions were chosen to allow a full 
digestion of the intermediated plasmids used for the assembly of pIRMM-0069, it is 
very difficult to prove that all plasmid populations were indeed fully digested, as 
traces of undigested plasmids will not be visible after gel electrophoresis and EtBr 
staining. 
The E. coli cells could, consequently be transformed with 3 populations of plasmids: 
pIRMM-0069 present in large amount and traces of both undigested pIRMM-0067 
and pIRMM-0068. However, as those 3 synthetic plasmids have the same origin of 
replication (oriV from ColE1 plasmid) they belong to the same incompatibility group. 
As a result, the transformed bacterial clones can only bear one single plasmid.  As 
the plasmid production was intended to be started from a unique colony, only one 
type of plasmid can be present in a single colony. We could therefore conclude that 
each single bacterium extracted from one colony contains only one type of plasmid5. 
As additional proof of purity, plasmid DNA isolated from the transformed E. coli cells 
was sequenced completely to verify that both target DNAs were present and correctly 
cloned. The sequence analysis did not reveal the presence of a mixed population of 
plasmids. 
 
Participants had the possibility to use any other type of calibrant which they think 
enables them to report the copy number ratio of 1507 and hmg fragments. 
 
5.3 Homogeneity testing 
 
Homogeneity analysis of the DNA sequences was performed at IRMM, where 19 
vials were analysed using a QRT-PCR method. The relative standard deviation was 
found to be less than 12 %. The sample intake used for determining the homogeneity 
was 200 mg. 
                                                 
5
 The synthetic vectors used (pUC18 and pCR2.1) in our cloning strategy were chosen as 
being high copy vectors from the same incompatibility group (incQ). Those plasmids have 
their own origin of replication (oriV) and are able to replicate independently of the host 
chromosome. A bacterial host cannot however contain different plasmids that have the same 
mechanisms of replication, because the control of the replication (in Gram negative bacteria) 
is exercised through trans-acting molecules (theta replication mode). The inevitable 
consequence of this is that one of the plasmids would eventually be lost from the cell simply 
as a result of random partitioning of plasmids into daughter cells during cell division. Thus the 
plasmids would appear to be incompatible. Two or several plasmids from the same 
incompatibility group cannot coexist in the same cell. 
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5.4 Stability testing 
 
As the 1507 plasmid calibrant ERM-AD418 has been produced following the same 
procedure as the ERM-AD413 produced in November 2006 and is of the same 
nature, long term-stability study for the ERM-AD418 was replaced by a post-
certification study of the stability of ERM-AD413 for a period of 12 and 24 months. 
Tubes containing the ERM-AD413 have been stored to -20 °C and 18 °C to be 
analysed at those respective time. The tubes stored for a period of 12 months were 
analysed (Fig. 3). The data for the 24 months will only be available in November 
2008. On the basis of the 12 months stability study, a shelf-live of 24 months can be 
guaranteed with a relative uncertainty of 8.4 % and 8.5 % for the material stored at 
18°C or -20°C, respectively. 
 
 
0,500
1,000
1,500
0 2 4 6 8 10 12 14
Time [month]
.
stored at -20 °C
stored at 18 °C
Linear (stored at -20 °C)
Linear (stored at 18 °C)
 
   
Figure 3: Long-term stability of plasmid DNA (ERM-AD413, MON 810 calibrant) 
stored at -20 °C and 18 °C for 12 months based on rt-PCR measurements. The 
stability is expressed as the ratio between the number ratio of MON 810 and hmg 
fragments per plasmid in samples stored at -20 °C or 18 °C and that in sample stored 
for the same period at the reference temperature (-70 °C), with the bars indicating the 
expanded uncertainty interval ± U (k = 2). Each bullet corresponds to the average of 
5 to 11 measurements. The dashed line is the regression line generated on the basis 
of the -20 °C data points, whereas the full line is the regression line generated on the 
basis of the 18 °C data points. 
 
Based on the 12 month stability study of ERM-AD413, a minimum shelf live of 24 
months at -20 °C can be guaranteed with a relative uncertainty (ults) of 8.5 %. As the 
number ratio stays unchanged for tubes stored at -20 °C or at 18 °C, the material will 
not suffer from storage at 4°C. The apparent trend visible in Figure 3 proves to be not 
statistically significant at a confidence level of 95%. 
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5.5 Instructions for use 
 
Participants have received four glass bottles. Two of those bottles contained 1 g of 
ERM-BF418b and 2 bottles contained ERM-BF418c. Those samples should be 
stored at 4 ºC. A tube containing the candidate ERM-AD418 calibrant should be 
stored at -20 °C.  
Participants were requested to analyse the 4 samples on 2 different days: 
Day 1 
 
1. Three independent DNA extractions from sample 1 (U1 to U3) and sample 2 (U4     
to U6) containing an unknown amount of copies of the 1507 event 
2. DNA quantification of U1 to U3 and of U4 to U6 
3. Preparation of dilutions of the plasmid DNA or any other suitable calibrant 
4. Real-time PCR (or other methods quantifying DNA fragments) 
 
Day 2 
 
On Day 2 steps 1 to 4 will be repeated performing three DNA extractions (U7 to U9) 
from sample 3 and (U10 to U12) for sample 4. 
A detailed protocol on the use of the calibrant will be provided along with the 
samples. The general use of such calibrant is also described in the ERM Technical 
Note 56. 
 
 DNA extracted from: Preparation of dilution series from: 
          :  
 
Day 1 Sample 1 U1, U2, U3         Calibrant 1 or any other suitable calibrant 
 Sample 2 U4, U5, U6   
Day 2 Sample 3 U7, U8, U9 New dilution of calibrant 1 or any other suitable 
Sample 4 U10, U11, U12   calibrant 
     
     
5.6 Methodology 
 
Participants were requested to use their preferred methodology for the extraction of 
genomic DNA from the samples. Special care should be taken to prepare highly 
purified genomic DNA. The unknowns could be diluted to verify the absence of PCR 
inhibitors in the extracted DNA. The extraction method referred to by the CRL for GM 
Food and Feed can for example be applied7. 
QRT-PCR is the most commonly used method to quantify DNA sequences but other 
technologies can also be used. The PCR platform and chemistry could be chosen by 
the participants. One laboratory performed digital PCR on a BiomarkTM system with 
digital arrays. 
 
 
                                                 
6
 http://www.erm-
crm.org/html/ERM_products/application_notes/application_note_5/application_note_5_english.pdf 
 
7
 http://gmo-crl.jrc.it/summaries/TC1507-DNAextrc.pdf 
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6 Participants 
 
The 14 NMIs or designated laboratories were originating from 4 continents and 
distributed between the Asian-Pacific (8 participants) and North American (3 
participants) regions and Europe (3 participants). The Asian-pacific participation was 
strongly represented and provided more than half of the total number of data sets.  
 
 
Table 1: List of the participants to the CCQM P113 pilot study and contact 
person.  * Organising laboratory. 
 
Thailand NIM- Thailand                        Duangkamol Viroonudomphol 
 DMSC-Thailand Nittaya Phunbua 
Rep of China NMI PR China  Yunhua Gao   
Hong Kong  Hong Kong Government Lab  Chun-yin Mak 
Japan NFRI  Satoshi Furui 
 NMI Mamoru Kawaharasaki 
Rep of Korea KRISS Hyong-Ha Kim   
Australia  NMIA  Kerry Emslie 
Canada NIM Mike Rott 
USA  NIST  Marcia Holden 
Mexico CENAM Melina Pérez Urquiza 
United Kingdom  LGC  Malcolm Burns 
European Commission IRMM* Philippe Corbisier 
Russian Federation VNIIM Maxim Vonsky  
 
7 Timing 
 
The laboratories had to signup for the pilot study before 1st of February 2008, the 
material was sent in the week of 24th March 2008 and results had to be submitted 
before the 6th of June 2008. A few results came later but were still accepted for the 
study. This draft report has been sent on 1st of November 2008 to be discussed at 
the Bioanalysis Group Meeting in Bangkok on 18th November 2008. 
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8 Results 
 
The results reported here are those reported for the sample 1 to 4 and expressed in 
percentage of 1507 copies per hmg copies. Each laboratory has received a random 
identification number. Affiliations are not disclosed. 
 
The copies number percentage for samples 1 and 3 were chosen to be at 1/20 of the 
level of the European labelling threshold for food and feed. It represents a very low 
number of 1507 copies in the sample (about 10 copies of 1507 targets per PCR). 
Several laboratories have reported the measured value as being under the practical 
limit of detection for the subsequent dilutions. In a few cases, the measured Ct 
values were outside the calibration curves. In this report, the GM percentages have 
been calculated on basis of the undiluted samples to have an idea about the 
performance of the QRT-PCR at very low copy number.  
 
9 Extraction method applied 
 
The DNA extraction method that was applied to extract the genomic DNA from the 
samples was left to the discretion of the laboratories and are summarised in Figure 1 
and 2. 
 
 
CCQM P-113
Samples 1 and 3
0.000
0.010
0.020
0.030
0.040
0.050
0.060
0.070
0.080
0.090
0.100
CTAB w/wo
mofications
Dneasy Plant Mini kit GM quicker Promega  Wizard
modified
extraction method applied
15
07
 
co
n
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n
t [
%
]
 
Fig 1: DNA extraction method applied on samples 1 and 3.   
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CCQM P-113
Samples 2 and 4
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Fig 2: DNA extraction method applied on samples 2 and 4.  
 
The Dneasy and GM quicker methods were each applied by one single laboratory, 
whereas the other laboratories performed either a CTAB method with for some an 
additional final purification step on a column or applied the Promega Wizard 
extraction protocol which is using property binding columns from which DNA is 
eluted. There is no clear indication that one extraction method provides better 
quantification results than another. However a statistical analysis still needs to be 
performed. 
 
10 Results 
 
10.1 Sample 1 
 
The sample 1 has been quantified by real-time PCR. Lab2b did an additional 
absolute quantification of the respective number of 1507 and hmg copies by digital 
PCR. The value reported by Lab2b is in very good agreement with the expected 
reference value. 
The labs 9 and 10 are outliers and data should be confirmed by those laboratories. 
The value for lab 10 is based on an average of sample 1 and 3 as individual data 
points could not be retrieving. The PCR efficiencies for Lab 10 were very low 
suggesting some serious problem with the measurement. 
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CCQM P-113
sample 1
0,00
0,05
0,10
0,15
0,20
0,25
Lab 2a Lab 8 Lab 11 "CRM" Lab 14 Lab 7 Lab2b Lab 6 Lab 4 Lab 3 Lab 12 Lab 5 Lab 9 Lab 1 Lab 10 Lab 13
15
07
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n
t [
%
]
< LOD
 
Fig 3: Distribution of the average GM content measured on sample 1. Error bars 
represented the expanded uncertainty (k = 2).  Lab 13 reported the value as being 
below their LOD. 
 
The “CRM” value has been extrapolated as being 1/9.9 of the currently estimated 
value of 0.49 % ± 0.14 as samples 1 and 3 contains 9.9 times less 1507 mass than 
sample 2 and 4. The CRM is bracketed as the certificate has not yet been released. 
 
 
10.2 Sample 3 
CCQM P-113
sample 3
0,00
0,05
0,10
0,15
Lab 5 Lab 2a Lab 8 Lab 7 Lab 14 Lab 6 "CRM" Lab 9 Lab2b Lab 3 Lab 4 Lab 11 Lab 1 Lab 12 Lab 10
15
07
 
c
o
n
te
n
t [
%
]
 
Fig 4: Distribution of the average GM content measured on sample 3. Error bars 
represented the expanded uncertainty (k = 2).  
 
The sample 3 was the same as sample 1 but the DNA was extracted and analysed 
on another day. The results are similar to those observed for sample 1. 
0.
34
 
±
 
0.
06
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10.3 Sample 2  
 
CCQM P-113
sample 2
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
Lab 10 Lab 11 Lab 2 Lab 14 Lab 7 Lab 6 "CRM" Lab 8 Lab 13 Lab 9 Lab 3 Lab 4 Lab 5 Lab 1 Lab 12
15
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o
n
te
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%
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*
 
Fig 5: Distribution of the average GM content measured on sample 2. Error bars 
represented the expanded uncertainty (k = 2). * no uncertainty reported. 
 
The sample 2 has been analysed by 35 laboratories in an inter comparison trial. The 
candidate CRM is estimated to have a 1507 copy number ratio of 0.49 ± 0.14 %. 
That value is also reported by several NMIs, however the data points are fluctuating 
between 0.35 and 1 %. 
 
10.4 Sample 4 
 
CCQM P-113
sample 4
0,00
0,20
0,40
0,60
0,80
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1,20
Lab 2 Lab 11 Lab 7 Lab 14 "CRM" Lab 8 Lab 6 Lab 13 Lab 9 Lab 1 Lab 12 Lab 3 Lab 4 Lab 10 Lab 5
15
07
 
c
o
n
te
n
t [
%
]
*
 
Fig 6: Distribution of the average GM content measured on sample 1. Error bars 
represented the expanded uncertainty (k = 2). * no uncertainty reported. 
 
The sample 4 was identical as sample 2 but the DNA was extracted and analysed on 
another day. 
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10.5 Combined samples 1 and 3 
 
 
CCQM P-113
sample 1- 3
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Fig 7: Distribution of the average GM content measured on samples 1 and 3. Error 
bars represented the expanded uncertainty (k = 2). 
 
Most laboratories do have a very good repeatability of their measurement at this very 
low number of 1507 target DNA copies. 
10.6 Combined samples 2 and 4 
 
CCQM P-113
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Fig 8: Distribution of the average GM content measured on samples 2 and 4. Error 
bars represented the expanded uncertainty (k = 2). * no uncertainty reported. 
 
Despite the higher concentration of 1507 targets in samples 2 and 4 compared to 1 
and 3, the repeatability does not seem to be improved for several laboratories. 
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11 Summary table 
 
Table 2 provides a summary of the average GM quantification reported in the 4 
samples together with the calculated expanded uncertainty (k=2). 
 
  
sample 1 sample 3 sample 2 sample 4 
  mean U mean U mean U mean U 
Lab 1 0.08 ± 0.04 
 
<LOD  0.81 ± 0.12 0.62 ± 0.11 
Lab 2a 0.039 ± 0.014 0.03 ± 0.013 0.342 ± 0.07 0.321 ± 0.073 
Lab 2b 0.052 ± 0.010       
Lab 3 0.055 ± 0.025 0.055 ± 0.025 0.67 ± 0.17 0.66 ± 0.17 
Lab 4 0.055 ± 0.015 0.67 ± 0.12 
Lab 5 0.065 ± 0.035 0.019 ± 0.013 0.69 ± 0.24 0.76 ± 0.25 
Lab 6 0.052 ± 0.012 0.048 ± 0.009 0.49 ± 0.0996 0.52 
± 
0.1037 
Lab 7 0.05 ± 0.02 0.04 ± 0.02 0.4 ± 0.1 0.5 ± 0.1 
Lab 8 0.04 ± 0.02 0.49 ± 0.19 
Lab 9 0.07 ± 0.06 0.05 ± 0.06 0.53 ± 0.19 0.53 ± 0.16 
Lab 10 0.22 ± 0.03 0.34 ± 0.06 0.20 ± 0.02 0.74 ± 0.13 
Lab 11 0.041 ± 0.03 0.06 ± 0.03 0.301 ± 0.07 0.41 ± 0.13 
Lab 12 0.056 ± 0.01 0.07 ± 0.02 0.89 ± 0.41 0.64 ± 0.18 
Lab 13 
    0.492  0.521  
Lab 14 0.044 ± 0.14 0.442 ± 0.085 
All Labs 0.06  0.05  0.56  0.53  
"target" value sample 2/4 
 0.49 ± 0.21   
CCQM 113 0.05 ± 0.01     0.55 ± 0.06     
 
12 Conclusions 
 
The goal of this CCQM 113 pilot study was to demonstrate the ability to quantify DNA 
sequences present in a biological tissue using an independent calibration system. 
The quantification has been performed by QRT-PCR. One laboratory has performed 
an absolute quantification of both targets by digital PCR without the use of an 
external standard on sample 1 and found precisely the expected GM concentration. 
This result reveals the potential of such new technology for absolute quantification of 
DNA targets. 
 
The samples 1 and 3 had a very low number of 1507 targets which has created some 
difficulties for several laboratories as the unknown samples were too diluted and 
falling outside calibration curves. The data for the undiluted samples have 
nevertheless been reported here. 
 
Most participating NMIs managed to quantify the 4 samples with high accuracy and 
reported measurements very close to the assigned value. They could clearly 
demonstrate their ability to quantify DNA sequences in a biological tissue. 
 
The assigned value of sample 2 and 4 is based on inter laboratory comparison 
including 35 data sets. The list of those participating laboratories is given in Annex 1. 
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The expanded uncertainty associated to that material comprises standard uncertainty 
contributions from the characterisation, the heterogeneity, and the stability and is 
reported in Annex 2. 
 
The expanded uncertainties (k = 2) related to those measurements have been 
calculated in different ways and are varying a lot between the laboratories. The 
uncertainties have been determined either by the bottom-up or top-down 
approaches. Details received from the participating laboratories are given in Annex 5. 
 
13 Contributors to the study 
 
CENAM: Melina Perez Urquiza, Martha Graciela Rocha Munive (INE-CENAM) 
DMSC Thailand: Nittaya Phunbua 
Hong Kong Government Laboratory: Chun-yin Mak 
IRMM: Philippe Corbisier, Sandra Vincent, Heinz Schimmel 
KRISS: Hyong-Ha Kim, Woo Jeong Kim 
LGC: Carole Foy, Steve Ellison, Malcolm Burns  
NFRI: Satoshi Furui 
NIST: Marcia Holden, Marc Salit, Ross Haynes 
NMI Canada: Mike Rott 
NMI China: Gao Yunhua 
NMI Japan: Mamoru Kawaharasaki  
NMI Thailand: Duangkamol Viroonudomphol 
NMIA: Kerry Emslie, Lina Partis, Somanath Bhat, Thosaporn Coldham, Daniel Burke, 
Vicki Rui Dan Xie and Gusharan Bains 
VNIIM: Maxim Vonsky 
 
14 Annex 1 : Laboratories involved in the certification 
of the samples 2 and 4 (ERM-AD418c) 
 
-Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Dienststelle 
Oberschleißheim, DE* (Staatliche Anerkennungsstelle der Lebensmittelüberwachung, SAL-
BY-L20-04-03)  
-Crop Research Institute, Prague 6 – Ruzyne, CZ* (Czech accreditation institute, nº8/2007) 
-Danish Plant Directorate, Laboratory for Diagnoses in Plants, Food and Feed Lyngby, DK* 
(DANAK 330) 
-Ente Nazionale Delle Sementi Elette (ENSE), Laboratorio Analisi Sementi, Tavazzano, IT* 
(ISTA IT03) 
-Eurofins Analytik GmbH - WEJ Dept Biology 135, Hamburg, DE* (Deutsches 
Akkreditierungssystem Prüfwesen GmbH, DAP-PL-1453.00) 
-European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM) - RM Unit, Geel, BE* (BELAC, 268-test) 
-Finnish Customs Laboratory - Tullilaboratorio, Espoo, FI* (FINAS, T006) 
-Groupe d'études et de contrôle des variétés et des semences (GEVES) - BioGEVES, 
Surgères, FR* (COFRAC, 1-1540) 
-Hainaut Vigilance Sanitaire - Institut Provincial d'Information et d'Analyses Sanitaires, Mons, 
BE* (Beltest, M-089T) 
-Federale Overheidsdienst (FOD) Volksgezondheid, Veiligheid van de Voedselketen en 
Leefmilieu Wetenschappelijk Instituut Volksgezondheid, Afdeling Bioveiligheid en 
Biotechnologie, Brussel, BE* (BELAC, 081-test) 
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-Institut für Hygiene und Umwelt – Behörde für Umwelt und Gesundheit, Hamburg, DE* 
(Deutsches Akkreditierungsstelle Chemie GmbH, DAC-PL-0137-01-10) 
-Instituut voor Landbouw- en Visserijonderzoek (ILVO), Melle, BE* (BELAC, 033-test) 
-Korea Research Institute of Standards and Science (KRISS) - Organic and Bio Analysis 
Group, Daejeon, KR 
-Landesamt für Umweltschutz Sachsen-Anhalt, FG 13 Gentechnisches Überwachungslabor, 
Halle/Saale, DE* (AKS, AKS-PL-21505) 
-Lifeprint GmbH, Illertissen, DE* (Deutsches Akkreditierungssystem Prüfwesen GmbH, DAP-
PL-3515.00) 
-Livsmedelsverket - National Food Administration – Biology Division, Uppsala, SE* 
(SWEDAC, 1457) 
-National Food Research Institute (NFRI) - Molecular Engineering Lab, Tsukuba, JP* 
(International Accreditation Japan, ASNITE 0018R) 
-National Institute for Food Safety and Nutrition, Budapest, HU* (NAT, NAT-1-1161/2003) 
-National Institute of Biology (NIB), Ljubljana, SI* (Slovenska akreditacija, LP-028) 
-National Veterinary Laboratory of the Republic of Lithuania, Vilnius, LT* (Deutsches 
Akkreditierungssystem Prüfwesen GmbH, DAP-PL-3328.99) 
-Nestlé Research Center Lausanne (Nestec S.A.) - Department Quality & Safety Assurance, 
Lausanne, CH* (Swiss Accreditation Service, STS 188) 
-New Technical University of Denmark - National Food Institute, Søborg, DK* (DANAK, 350) 
-Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES), 
Lebensmittelinstitut Braunschweig, Braunschweig, DE* (Staatliche Akkreditierungsstelle 
Hannover, AKS-PL-10301) 
-Ontario Plant Laboratories - Canadian Food Inspection Agency - Ottawa Laboratory 
Fallowfield, Ottawa, CA* (Standards Council of Canada, 316) 
-Scottish Agricultural Science Agency - Diagnostics & Molecular Biology Section, Edinburgh, 
UK 
-Staatliches Gewerbeaufsichtsamt Hildesheim - Dez 33 Gentechnik, Hildesheim, DE* 
(Deutsches Akkreditierungsstelle Chemie GmbH, DACH/DAC-P-0257-04-00) 
-TNO Nutrition and Food Research - GMO foods, Zeist, NL* (Dutch accreditation council RvA 
L027) 
-Umweltbundesamt Wien (UBA Wien), Vienna, AT* (Federal Ministry of Economics and 
labour, 200) 
-USDA, Grain Inspection, Packers and Stockyards Administration - Technical Services 
Division, Kansas City, USA 
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15 Annex 2 : Uncertainty budget for the number 
fraction of maize event 1507 in the candidate 
calibrant ERM-AD418 
 
The value is the number of each cloned DNA fragment per plasmid. The number ratio 
between those two DNA fragments is given as an indicative value measured by 
simplex real-time PCR.  
 
substance value 
[number] 
 
Uncertainty  
 
Fragment of 3’-insertion-specific DNA per  
plasmid pIRMM -0069 a) 
1  negligible  
Fragment of hmg DNA per plasmid pIRMM -0069 1) 1 negligible 
 
 Indicative 
value  
[number 
ratio] 
Uncertainty c) 
[number 
ratio] 
Ratio between the numbers of 3’-insertion-specific DNA 
and hmg fragments in the plasmid pIRMM -0069 
 
1.00 b) 
 
0.14 
 
a) The 100 % sequence identity has been confirmed by dye terminator cycle sequencing of the 
hmg and 3’ insert-plant junction fragments both present in Zea mays DAS-Ø15Ø7-1. 
 
b) The number ratio for the two DNA fragments has been characterised by simplex QRT-PCR 
targeting each cloned fragment. 
 
c) The uncertainty is the expanded uncertainty estimated in accordance with the Guide to the 
Expression of Uncertainty in Measurement (GUM) with a coverage factor k = 2, 
corresponding to a level of confidence of about 95 %. 
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16 Annex 3: Uncertainty budget for the DNA copy 
number ratio of 1507 maize in ERM-BF418c.  
The expanded uncertainty of the value (UCRM) comprises standard uncertainty 
contributions from the characterisation, the heterogeneity, and the stability. 
2
lts
2
bb
2
char uuukUCRM ++=  
with k = 2 
The uncertainty from the characterisation has been assessed during the 
interlaboratory comparison by estimating the RSD of the normally distributed data. 
The standard uncertainty (uchar) related to the characterisation is calculated using the 
formula:  
N
s
u =char  
 
Where s =  standard deviation 
N = number of data sets, in this study N = 35. 
The uncertainty introduced by the heterogeneity at 200 mg level has been estimated 
on the basis of the heterogeneity of a normally distributed population. The uncertainty 
contribution from the stability (ults) has been estimated on the basis of QRT-PCR 
results following long-term storage of ERM-BF418c. A coverage factor of 2 (k = 2) 
was used to calculate the expanded uncertainty corresponding to a level of 
confidence of about 95 %.  
The standard uncertainty contribution introduced by the long-term stability is larger 
than the standard uncertainty contributions from the characterisation and from the 
heterogeneity of the maize powders. 
The value reported here is NOT the certified value as the material has not yet been 
released. 
 
Value8  [%] Standard uncertainty 
contributions [%] 
Expanded 
uncertainty UCRM  
(k = 2) [%] 
 ubb 
a)
 ults
 b)
 uchar 
c)
 UCRM 
0.49 0.041 0.054 0.016 0.14 
a)
 Standard uncertainty introduced by the heterogeneity at 200 mg level. 
b)
 Standard uncertainty related to the stability, estimated on the basis of a shelf life of 18 
months. 
c)
 Standard uncertainty introduced by the characterisation. 
 
                                                 
8
 Please note that as the material has not yet been released the value reported here is NOT the certified 
value. 
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17 Annex 3: Primer and probe sequences used for the 
quantification of the hmg and 1507 event-specific 
rt-PCR. 
 
 
Sequence (5’ to 3’) 
1507-F primer (P-0487) TAg TCT TCg gCC AgA ATg g 
1507-R primer (P-0488) CTT TgC CAA gAT CAA gCg 
1507 probe (P-0489) 6-(FAM)-TAA CTC AAg gCC CTC ACT CCg-TAMRA- 
hmg probe 6-(FAM)-CAA TCC ACA CAA ACg CAC gCg TA-TAMRA 
hmg -F primer TTg gAC TAg AAA TCT CgT gCT gA 
hmg -R primer gCT ACA TAg ggA gCC TTg TCC T 
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18 Annex 4 : Statistical analysis of the P-113 pilot 
study 
Lab Alias  Abbreviation Lab Full Name                                                                                Person Name / Telephon                             
L0         Lab1                                   not disclosed                                                                     not disclosed                                                  
L1         Lab2                                   not disclosed                                                                                 not disclosed                                
L2         Lab3                                   not disclosed                                                                                 not disclosed                               
L3         Lab4                                   not disclosed                                                                                not disclosed                                
L4         Lab5                                   not disclosed                                                                                 not disclosed                               
L5         Lab6                                   not disclosed                                                                             not disclosed                               
L6         Lab7                                   not disclosed                                                                            not disclosed                                
L7         Lab8                                   not disclosed                                                                                 not disclosed                                
L8         Lab9                                   not disclosed                                                                    not disclosed                                                 
L9         Lab11                                  not disclosed                                                                         not disclosed                                                 
L10        Lab12                                  not disclosed                                                                              not disclosed                                                 
L11        Lab13                                  not disclosed                                                                               not disclosed                                                 
L12        Lab14                                  not disclosed                                                                                not disclosed                                                 
 
Be aware that the Lab alias number in Annex 4 are different than the Lab number reported in the section 8. L0 corresponds to lab 
1, L1 corresponds to Lab 2, etc... 
The data of lab 10 have not been included as some clarification from Lab 10 is first needed. 
 
Samples 2 and 4 
 
Data from the Lab: L1 
Mean of Lab ± StDev =  0,608 ± 0,052       [ CV(%) = 8,6 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,53 0,495 
Rep #2 0,698 0,636 
Rep #3 0,706 0,581 
 
Mean 0,645 0,571 
STDev 0,099 0,071 
CV(%) 15,416 12,453 
 
 
Data from the Lab: L2 
Mean of Lab ± StDev =  0,330 ± 0,019       [ CV(%) = 5,7 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,36 0,29 
Rep #2 0,36 0,29 
Rep #3 0,31 0,37 
 
Mean 0,343 0,317 
STDev 0,029 0,046 
CV(%) 8,408 14,586 
 
 
Data from the Lab: L3 
Mean of Lab ± StDev =  0,655 ± 0,006       [ CV(%) = 0,9 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,638 0,658 
Rep #2 0,721 0,766 
Rep #3 0,594 0,555 
 
Mean 0,651 0,660 
STDev 0,064 0,106 
CV(%) 9,906 15,994 
 
 
Data from the Lab: L4 
Mean of Lab ± StDev =  0,795 ± 0,064       [ CV(%) = 8,1 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,821 0,775 
Rep #2 0,848 0,734 
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Rep #3 0,853 0,74 
 
Mean 0,841 0,750 
STDev 0,017 0,022 
CV(%) 2,048 2,954 
 
 
Data from the Lab: L5 
Mean of Lab ± StDev =  0,837 ± 0,203       [ CV(%) = 24,2 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 1,4 0,55 
Rep #2 0,7 0,91 
Rep #3 0,84 0,62 
 
Mean 0,980 0,693 
STDev 0,370 0,191 
CV(%) 37,796 27,530 
 
 
Data from the Lab: L6 
Mean of Lab ± StDev =  0,508 ± 0,025       [ CV(%) = 4,9 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,436 0,621 
Rep #2 0,556 0,473 
Rep #3 0,478 0,482 
 
Mean 0,490 0,525 
STDev 0,061 0,083 
CV(%) 12,427 15,794 
 
 
Data from the Lab: L7 
Mean of Lab ± StDev =  0,454 ± 0,015       [ CV(%) = 3,3 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,476 0,462 
Rep #2 0,485 0,463 
Rep #3 0,434 0,406 
 
Mean 0,465 0,444 
STDev 0,027 0,033 
CV(%) 5,854 7,353 
 
 
Data from the Lab: L8 
Mean of Lab ± StDev =  0,495 ± 0,016       [ CV(%) = 3,2 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,603 0,514 
Rep #2 0,485 0,443 
Rep #3 0,43 0,493 
 
Mean 0,506 0,483 
STDev 0,088 0,036 
CV(%) 17,469 7,546 
 
 
Data from the Lab: L9 
Mean of Lab ± StDev =  0,527 ± 0,005       [ CV(%) = 0,9 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,52 0,53 
Rep #2 0,56 0,53 
Rep #3 0,49 0,53 
 
Mean 0,523 0,530 
STDev 0,035 0,000 
CV(%) 6,711 0,000 
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Data from the Lab: L11 
Mean of Lab ± StDev =  0,357 ± 0,079       [ CV(%) = 22,2 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,34 0,563 
Rep #2 0,253 0,308 
Rep #3 0,31 0,369 
 
Mean 0,301 0,413 
STDev 0,044 0,133 
CV(%) 14,682 32,215 
 
 
Data from the Lab: L12 
Mean of Lab ± StDev =  0,765 ± 0,177       [ CV(%) = 23,1 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 1,21 0,49 
Rep #2 0,86 0,68 
Rep #3 0,6 0,75 
 
Mean 0,890 0,640 
STDev 0,306 0,135 
CV(%) 34,394 21,021 
 
 
Data from the Lab: L13 
Mean of Lab ± StDev =  0,600 ± 0,009       [ CV(%) = 1,6 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,59 0,59 
Rep #2 0,57 0,64 
Rep #3 0,62 0,59 
 
Mean 0,593 0,607 
STDev 0,025 0,029 
CV(%) 4,241 4,758 
 
 
Data from the Lab: L14 
Mean of Lab ± StDev =  0,442 ± 0,029       [ CV(%) = 6,6 ] 
 Sample #2 Sample #4 
Sample's ID =>   
Rep #1 0,455 0,396 
Rep #2 0,458 0,441 
Rep #3 0,473 0,426 
 
Mean 0,462 0,421 
STDev 0,010 0,023 
CV(%) 2,087 5,442 
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Summary Table 
Labs Mean U(k=2) [%] STDev Standard 
Error 
H.W.  CI 
(95%) 
Sample #2 Sample #4 
L1 0,608 0,0 0,052 0,037 0,470 0,645 0,571 
L2 0,330 0,0 0,019 0,013 0,169 0,343 0,317 
L3 0,655 0,0 0,006 0,004 0,055 0,651 0,660 
L4 0,795 0,0 0,064 0,046 0,578 0,841 0,750 
L5 0,837 0,0 0,203 0,143 1,821 0,980 0,693 
L6 0,508 0,0 0,025 0,018 0,224 0,490 0,525 
L7 0,454 0,0 0,015 0,011 0,136 0,465 0,444 
L8 0,495 0,0 0,016 0,011 0,144 0,506 0,483 
L9 0,527 0,0 0,005 0,003 0,042 0,523 0,530 
L11 0,357 0,0 0,079 0,056 0,714 0,301 0,413 
L12 0,765 0,0 0,177 0,125 1,588 0,890 0,640 
L13 0,600 0,0 0,009 0,007 0,085 0,593 0,607 
L14 0,442 0,0 0,029 0,021 0,260 0,462 0,421 
 
  
 Case of No Pooling Case of Pooling 
# of Determinations  13 26 
Range [min..max] [ 0,330 .. 0,837 ] [ 0,301 .. 0,980 ] 
Average of Dataset  0,567 0,567 
StDev of Average  0,162 0,169 
R.S.D. of Average(%)  28,506 29,825 
S.E. of Average  0,045 0,033 
R.S.E. of Average(%)  7,906 5,849 
95% H.W. Confidence Interval 0,098 0,068 
95% H.W. Tolerance Interval 0,498 0,442 
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STATISTICAL ANALYSIS FOR CCQMP116_ 0.49 % 
 
Labs           Method        Mean           STDev     H.W.  CI (95%)     Samp#2         Samp#4     
L0  -L1                   0,608          0,052          0,470          0,645          0,571     
L1  -L2                   0,330          0,019          0,169          0,343          0,317     
L2  -L3                   0,655          0,006          0,055          0,651          0,660     
L3  -L4                   0,795          0,064          0,578          0,841          0,750     
L4  -L5                   0,837          0,203          1,821          0,980          0,693     
L5  -L6                   0,508          0,025          0,224          0,490          0,525     
L6  -L7                    0,454          0,015          0,136          0,465          0,444     
L7  -L8                    0,495          0,016          0,144          0,506          0,483     
L8  -L9                    0,527          0,005          0,042          0,523          0,530     
L9  -L11                   0,357          0,079          0,714          0,301          0,413     
L10 -L12                   0,765          0,177          1,588          0,890          0,640     
L11 -L13                   0,600          0,009          0,085          0,593          0,607     
L12 -L14                   0,442          0,029          0,260          0,462          0,421     
 
meas. units : % cp/cp 
 
-------------------------------------------------------------------------------- 
Number of accepted Data sets    (Labs)            13 
Number of Individual Data  (analysed samples)                26 
 
-------------------------------------------------------------------------------- 
Scheffe's multiple t-test 
All Data Sets compatible two by two?                       No 
-------------------------------------------------------------------------------- 
 
TESTING FOR OUTLYING LAB MEANS 
 
Dixon Test                                        (a=0.05) Outliers NOT Detected 
                                                  (a=0.01) Outliers NOT Detected 
 
 
Nalimov t-test                                    (a=0.05) Outliers NOT Detected  
                                                  (a=0.01) Outliers NOT Detected 
 
 
Grubbs test (Single)                              (a=0.05) Outliers NOT Detected 
                                                  (a=0.01) Outliers NOT Detected 
 
 
 
Grubbs test (Double)*                             (a=0.05) Outliers NOT Detected 
                                                  (a=0.01) Outliers NOT Detected 
 
 
* The Double Grubbs Test is valid only when the Single Grubbs Test 
  fails to detect any outlier 
-------------------------------------------------------------------------------- 
 
TESTING OF VARIANCES 
 
Cochran Test 
OutLying Lab variances?                           (a=0.05) No 
                                                                    (a=0.01) No 
 
Bartlett test 
Lab variances homogeneous?                        (a=0.05) Yes 
                                                                       (a=0.01) Yes 
-------------------------------------------------------------------------------- 
ANOVA 
 
Between Labs StDev                                                  0,261 % cp/cp 
Within Labs (between samples) StDev                      0,142 % cp/cp 
 
Snedecor F-test 
Differences between Labs statistically significant?                 (a=0.05) Yes 
                                                                                                 (a=0.01) Yes 
 
Differences within Labs (between samples) statistically significant?(a=0.05) No 
                                                                                                             (a=0.01) No 
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Samples 1 and 3 
 
Data from the Lab: L1 
Mean of Lab ± StDev =  0,064 ± 0,024       [ CV(%) = 37,8 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,061 0,040 
Rep #2 0,089 0,038 
Rep #3 0,094 0,063 
 
Mean 0,081 0,047 
STDev 0,018 0,014 
CV(%) 21,868 29,558 
 
 
Data from the Lab: L2 
Mean of Lab ± StDev =  0,038 ± 0,003       [ CV(%) = 7,4 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,050 0,020 
Rep #2 0,040 0,048 
Rep #3 0,030 0,040 
 
Mean 0,040 0,036 
STDev 0,010 0,014 
CV(%) 25,000 40,062 
 
 
Data from the Lab: L3 
Mean of Lab ± StDev =  0,055 ± 0,002       [ CV(%) = 3,0 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,054 0,031 
Rep #2 0,062 0,068 
Rep #3 0,053 0,063 
 
Mean 0,056 0,054 
STDev 0,005 0,020 
CV(%) 8,757 37,176 
 
 
Data from the Lab: L4 
Mean of Lab ± StDev =  0,088 ± 0,003       [ CV(%) = 3,7 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,072 0,085 
Rep #2 0,120 0,078 
Rep #3 0,080 0,095 
 
Mean 0,091 0,086 
STDev 0,026 0,009 
CV(%) 28,364 9,935 
 
 
Data from the Lab: L5 
Mean of Lab ± StDev =  0,065 ± 0,021       [ CV(%) = 32,9 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,07 0,02 
Rep #2 0,071 0,05 
Rep #3 0,1 0,08 
 
Mean 0,080 0,050 
STDev 0,017 0,030 
CV(%) 21,211 60,000 
 
 
Data from the Lab: L6 
Mean of Lab ± StDev =  0,050 ± 0,004       [ CV(%) = 7,0 ] 
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 Sample #1 Sample #2 
Sample's ID =>   
Rep #1 0,068 0,047 
Rep #2 0,042 0,053 
Rep #3 0,048 0,043 
 
Mean 0,053 0,048 
STDev 0,014 0,005 
CV(%) 25,849 10,559 
 
 
Data from the Lab: L7 
Mean of Lab ± StDev =  0,050 ± 0,002       [ CV(%) = 3,8 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,049 0,057 
Rep #2 0,039 0,039 
Rep #3 0,058 0,058 
 
Mean 0,049 0,051 
STDev 0,010 0,011 
CV(%) 19,530 20,830 
 
 
Data from the Lab: L8 
Mean of Lab ± StDev =  0,042 ± 0,002       [ CV(%) = 4,0 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,037 0,033 
Rep #2 0,052 0,048 
Rep #3 0,039 0,040 
 
Mean 0,043 0,040 
STDev 0,008 0,008 
CV(%) 19,089 18,609 
 
 
Data from the Lab: L9 
Mean of Lab ± StDev =  0,058 ± 0,017       [ CV(%) = 28,8 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,080 0,047 
Rep #2 0,050 0,050 
Rep #3 0,080 0,042 
 
Mean 0,070 0,046 
STDev 0,017 0,004 
CV(%) 24,744 8,723 
 
 
Data from the Lab: L11 
Mean of Lab ± StDev =  0,048 ± 0,010       [ CV(%) = 21,5 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,059 0,055 
Rep #2 0,034 0,080 
Rep #3 0,030 0,032 
 
Mean 0,041 0,056 
STDev 0,016 0,024 
CV(%) 38,332 43,126 
 
 
Data from the Lab: L12 
Mean of Lab ± StDev =  0,063 ± 0,009       [ CV(%) = 14,9 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,050 0,060 
Rep #2 0,050 0,080 
Rep #3 0,070 0,070 
 
Mean 0,057 0,070 
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STDev 0,012 0,010 
CV(%) 20,377 14,286 
 
 
Data from the Lab: L13 
Mean of Lab ± StDev =  0,056 ± 0,020       [ CV(%) = 36,4 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,050 0,11 
Rep #2 0,021 0,042 
Rep #3 0,053 0,058 
 
Mean 0,041 0,070 
STDev 0,018 0,036 
CV(%) 42,757 50,790 
 
 
Data from the Lab: L14 
Mean of Lab ± StDev =  0,044 ± 0,002       [ CV(%) = 5,4 ] 
 Sample #1 Sample #3 
Sample's ID =>   
Rep #1 0,037 0,063 
Rep #2 0,043 0,027 
Rep #3 0,057 0,037 
 
Mean 0,046 0,042 
STDev 0,010 0,019 
CV(%) 22,474 43,897 
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Summary Table 
Labs Mean U(k=2) [%] STDev Standard 
Error 
H.W.  CI 
(95%) 
Sample #1 Sample #3 
L1 0,064 0,0 0,024 0,017 0,218 0,081 0,047 
L2 0,038 0,0 0,003 0,002 0,025 0,040 0,036 
L3 0,055 0,0 0,002 0,001 0,015 0,056 0,054 
L4 0,088 0,0 0,003 0,002 0,030 0,091 0,086 
L5 0,065 0,0 0,021 0,015 0,193 0,080 0,050 
L6 0,050 0,0 0,004 0,002 0,032 0,053 0,048 
L7 0,050 0,0 0,002 0,001 0,017 0,049 0,051 
L8 0,042 0,0 0,002 0,001 0,015 0,043 0,040 
L9 0,058 0,0 0,017 0,012 0,150 0,070 0,046 
L11 0,048 0,0 0,010 0,007 0,093 0,041 0,056 
L12 0,063 0,0 0,009 0,007 0,085 0,057 0,070 
L13 0,056 0,0 0,020 0,014 0,182 0,041 0,070 
L14 0,044 0,0 0,002 0,002 0,021 0,046 0,042 
 
 Case of No Pooling Case of Pooling 
# of Determinations  13 26 
Range [min..max] [ 0,038 .. 0,088 ] [ 0,036 .. 0,091 ] 
Average of Dataset  0,056 0,056 
StDev of Average  0,013 0,016 
R.S.D. of Average(%)  23,590 28,131 
S.E. of Average  0,004 0,003 
R.S.E. of Average(%)  6,543 5,517 
95% H.W. Confidence Interval 0,008 0,006 
95% H.W. Tolerance Interval 0,040 0,041 
 
 
 
 
STATISTICAL ANALYSIS FOR CCQMP116_sample 1 and 3 
 
Labs           Method        Mean           STDev     H.W.  CI (95%)     Samp#1         Samp#3    
L0  -L1                0,064          0,024          0,218          0,081          0,047     
L1  -L2                0,038          0,003          0,025          0,040          0,036     
L2  -L3                0,055          0,002          0,015          0,056          0,054     
L3  -L4                0,088          0,003          0,030          0,091          0,086     
L4  -L5                0,065          0,021          0,193          0,080          0,050     
L5  -L6                0,050          0,004          0,032          0,053          0,048     
L6  -L7                0,050          0,002          0,017          0,049          0,051     
L7  -L8                0,042          0,002          0,015          0,043          0,040     
L8  -L9                0,058          0,017          0,150          0,070          0,046     
L9  -L11               0,048          0,010          0,093          0,041          0,056     
L10 -L12               0,063          0,009          0,085          0,057          0,070     
L11 -L13                0,056          0,020          0,182          0,041          0,070     
L12 -L14                0,044          0,002          0,021          0,046          0,042     
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meas. units : % cp/cp 
 
-------------------------------------------------------------------------------- 
Number of accepted Data sets    (Labs)            13 
Number of Individual Data  (analysed samples)                26 
 
-------------------------------------------------------------------------------- 
Scheffe's multiple t-test 
All Data Sets compatible two by two?                       No 
-------------------------------------------------------------------------------- 
 
TESTING FOR OUTLYING LAB MEANS 
 
Dixon Test                                    (a=0.05) Outliers Detected 
                                                   (a=0.01) Outliers NOT Detected 
Lab L3 is an outlier at a=0.05 
 
 
Nalimov t-test                            (a=0.05) Outliers Detected  
                                                  (a=0.01) Outliers Detected 
Lab L3 is an outlier at a=0.05 
Lab L3 is an outlier at a=0.01 
 
 
Grubbs test (Single)                  (a=0.05) Outliers Detected 
                                                  (a=0.01) Outliers NOT Detected 
 
Lab L3 is an outlier at a=0.05 
 
 
Grubbs test (Double)*               (a=0.05) Outliers Detected 
                                                  (a=0.01) Outliers NOT Detected 
Lab L3 is an outlier at a=0.05 
 
 
* The Double Grubbs Test is valid only when the Single Grubbs Test fails to detect any outlier 
-------------------------------------------------------------------------------- 
TESTING OF VARIANCES 
 
Cochran Test 
OutLying Lab variances?         (a=0.05) No 
                                                  (a=0.01) No 
 
Bartlett test 
Lab variances homogeneous?    (a=0.05)                                                  
                                                    (a=0.01) Yes 
-------------------------------------------------------------------------------- 
ANOVA 
 
Between Labs StDev                                                  0,017 % cp/cp 
Within Labs (between samples) StDev                      0,021 % cp/cp 
 
Snedecor F-test 
Differences between Labs statistically significant?                 (a=0.05) Yes 
                                                                                                  (a=0.01) Yes 
 
Differences within Labs (between samples) statistically significant?(a=0.05) No 
                                                                                                             (a=0.01) No 
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19 Annex 5 : Uncertainty calculations reported by the 
participating laboratories 
 
Lab 1 
 
Av. of GM/Ref (%) SD(%) UC form measurement, relative  (%) UC from each CRM, relative (%) UC from callibrant , relative(%)
Day1
Sample 1
0,080 0,017 21
-0.001;+0.080 1)
7 3)
Sample 2 0,81 0,026 3,2 -0.03;+0.04 2) 7 3)
Day2
Sample 3
Under 5 copies
Sample 4 0,62 0,032 5,2 -0.03;+0.04 2) 7 3)
For the select of GM/Ref value, I chose on the following points; -
1. All measurement value (4) are acceptabe +
2. Low template concentration is better than high conc for the inhibition.
-
References +
1)http://www.irmm.jrc.be/html/reference_materials_catalogue/catalogue/attachements/ERM-BF418b_cert.pdf Combined standard uncertainty (%)
2)http://www.irmm.jrc.be/html/reference_materials_catalogue/catalogue/attachements/ERM-BF418c_cert.pdf -
+
-
+
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Lab 2  
Measurement equation for real-time PCR:  
 
 
 
 
Definition of Symbols 
E  concentration of endogenous template in Unknown solution (copies/µL) 
Der dilution factor of Unknown used for real-time endogenous PCR  
T concentration of transgene template in Unknown solution (copies/µL) 
Dtr dilution factor of Unknown used for real-time transgene PCR 
me and mt slope of calibration curve for endogenous and transgene assays, respectively 
Ce and Ct intercept of calibration curve for endogenous and transgene assays, respectively 
Factors affecting uncertainty in result 
fst sampling error for transgene template 
fdt error in predicted response for transgene template 
fse sampling error for endogenous template 
fde error in predicted response for endogenous template 
fext factor accounting for extraction uncertainty 
fcal calibrant uncertainty 
fpcr PCR uncertainty 
Results 
Measurand: copy number fraction of 1507 to hmg, expressed as a 
percentage, in the samples provided 
Units:  percent copy number/copy number (% cp/cp) 
Coverage Factor (k): Coverage factor of 2 was used to determine the expanded 
uncertainty 
 
Sample 1 Sample 1 Sample 2 Sample 3 Sample 4 
Value Measured 0.039 % cp/cp 0.342 % cp/cp 0.030 % cp/cp 0.321 % cp/cp 
Combined standard 
uncertainty 
0.0069 % cp/cp 0.035 % cp/cp 0.0065 % 
cp/cp 
0.037 % cp/cp 
k (95%) 2 2 2 2 
Expanded 
Uncertainty 
0.014 % cp/cp 0.070 % cp/cp 0.013 % cp/cp 0.073 % cp/cp 
 Relative expanded 
uncertainty 
35.8 % 20.5 % 43.8 % 22.9 % 
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CCQM-P113 Sample 2 (real-time PCR)
Transgene -
stochastic effect -
35%
Calibrant
46%
PCR
3%
Transgene - 
Predicted value
7% Endogenous - 
Predicted value
7% Extraction
2%
Endogenous -
stochastic effect -
0%
CCQM-P113 Sample 1 (real-time PCR)
Extraction
7%
Endogenous -
stochastic effect
0%
Transgene - 
Predicted value
3%
Endogenous - 
Predicted value
2%
Transgene -
stochastic effect
72%
PCR
1%
Calibrant
15%
Breakdown in uncertainty 
  
 
  
 
 
 
 
 
CCQM-P113 Sample 3 (real-time PCR)
PCR
1%
Transgene - 
Predicted value
7%
Endogenous - 
Predicted value
1%
Extraction
5%
Endogenous -
stochastic effect -
0%
Calibrant
10%
Transgene -
stochastic effect -
76%
CCQM-P113 Sample 4 (real-time PCR)
Endogenous - 
Predicted value
3%
Extraction
2%
Endogenous -
stochastic effect -
0%
PCR
2%
Transgene - 
Predicted value
21%
Transgene -
stochastic effect -
34%
Calibrant
38%
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Lab 3 
 
The values and corresponding expanded uncertainties are: 
 
Sample 1: 0.055 %GM ± 0.025 %GM 
Sample 2: 0.67 %GM ± 0.17 %GM 
Sample 3: 0.055 %GM ± 0.025 %GM 
Sample 4: 0.66 %GM ± 0.17 %GM 
 
Expanded uncertainties are quoted with coverage factors based on Students’s t for the appropriate 
degrees of freedom. 
 
The reported uncertainty is based on the dispersion of the observations in a single analytical run 
combined in quadrature with the uncertainty for the calibration material. This estimate makes no 
allowance for matrix effects, calibrant mismatch, long-term variation, extraction or other effects, and is 
consequently considered to represent an extreme lower bound on the uncertainty. 
 
 
 
 
 
 
 
Lab 4 
The result of Unknown sample and uncertainty (sent Tue 08/07/2008 10:35) 
 Mean of all 
results 
 
Combined 
Standard 
Uncertainty 
Coverage 
factor 
Expanded standard uncertainty 
(95% confidence leve) 
Sample1 0.090506% 0.012% 2 0.024% 
Sample2 0.840629% 0.011% 2 0.022% 
Sample3 0.086116% 0.0099% 2 0.019% 
Sample4 0.749674% 0.011% 2 0.022% 
The result of Unknown sample and uncertainty (sent Mon 27/04/2009 03:34) 
 Mean of all 
results 
 
Combined 
Standard 
Uncertainty 
Coverage 
factor 
Expanded standard uncertainty 
(95% confidence leve) 
Sample1 0.091% 0.18 2 0.032% 
Sample2 0.84% 0.072 2 0.12% 
Sample3 0.086% 0.092 2 0.016% 
Sample4 0.75% 0.073 2 0.11% 
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Lab 5 
 
End (Avr. copy No.)Ramdom Variation (RV, %) GM (Avr. copy No.)RV(%) GM/END (C/C %) Combined standard uncertainty
Day1
Sample1 7500 1,6 4,9 25 0,065% 26
Sample2 7400 6,4 51 13 0,69% 16
Day2
Sample3 11300 4,2 2,1 54 0,019% 55
Sample4 11200 2,4 85 15 0,76% 17
Uncertainty Budget
Standard uncertainty
Calibration solution 7
Pipetting (calibrant dilution) 1,414213562
Pipetting (sample dilution) 1,802775638
Pipetting (reaction mixture) 2,236067977
Ramdom Variation of Endogeneous gene (RV1)
Ramdom Variation of GM gene (RV2)
59,25
UC of sample
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Lab 6 
 
Results 
Relative quantification of genomic DNA fragments extracted from a biological tissue CCQM-P113 
Participant Lab. No. 6
Result
U1 0,068
U2 0,042
U3 0,048
U4 0,436
U5 0,556
U6 0,478
U7 0,047
U8 0,053
U9 0,043
U10 0,621
U11 0,473
U12 0,482
* The ratio is an average of the undiluted and all the diluted samples.
Methodology Outline
1 DNA extraction from samples 1, 2, 3 and 4. The CTAB method used for CCQM-P60 study was used.
2 DNA quantification of all DNA extractions with PicoGreen® dsDNA quantitation.
3 Determination of the copy ratio by real-time PCR. ABI TaqMan Universal 2-fold Buffer was used instead of the 10x buffer.
4 Result obtained from diluted samples were also included in the calculation of the average cp ratio, e.g. the ratio of sample U1 is the 
average value of U1, U1-2x and U1-4x.
Relative quantification of genomic DNA fragments extracted from a biological tissue CCQM-P113 
Participant Lab. No. 6
Uncertainty Estimation
Expanded Uncertainty =
Standard Uncertainty, u =    SD/√N
Relative uncertainty, U rel  =    u /Mean ratio of the sample
Uncertainty of the calibrant, U CRM   =   0.14/2  = 0,07
Combined Uncertainty =
Coverage factor, k =    2
Concentration, c =    Mean ratio of the sample
Dr. Chun-yin MAK, Hong Kong Government Laboratory, Hong Kong
Dr. Chun-yin MAK, Hong Kong Government Laboratory, Hong Kong
0,52 0,0988
Relative Uncertainty, 
U rel 
0,0955
0,0738
0,0636
0,0697
Combined Uncertainty
The Expanded Uncertainty is calculated in accordance witht the Guide to the Expression of Uncertainty in Measurement (GUM) with a coverage 
factor k  = 2, corresponding to a level of confidence of about 95%.
Sample Sample Code Ratio 1507/hmg (%)*
Average cp ratio 
(%)
2 0,49
1 0,052
4
Expanded Uncertainty 
(%)SD
0,0150
0,1084
Standard Uncertainty, 
u
0,0050
0,0361 0,1017
0,1184
3 0,048
0,0124
0,0996
0,0090
0,1037
0,0030 0,09460,0091
0,1098 0,0366
2
 CRM
2
rel UU +
2
 CRM
2
rel UUck +
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Lab 7 
The expanded measurement uncertainty U for a concentration c and a coverage factor k= 2 was 
estimated as taking into account the method repeatability, intermediate precision calculated for the 2 
days and the uncertainty of the material. 
 
 
 
 
 
 
 
 
Day 1 Day 2 
ratio 1507/hmg % ratio 1507/hmg %
0,05 0,06
0,04 0,04
0,06 0,04
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
Sample 1 3 0,146201514 0,048733838 8,81E-05
Sample 3 3 0,134791662 0,044930554 0,000116
0,046832196
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 2,16975E-05 1 2,16975E-05 0,212823 0,668534 7,708647
Within Groups 0,000407803 4 0,000101951
Total 0,0004295 5
repeatability 21,6%
Method repeatability is the square of the within group MS divided by the average of the study
Between day variation 11,0%
measurement uncertainty exp u
uncertainty for 3 duplicates on 2 days 14,7% 29,4%
uncertainty of the calibrant measurement uncertainty
negligible 0,0072
expanded U rounded U
sample 1 0,05 ± 0,014 0,02
sample 3 0,04 ± 0,014 0,02
sample 1-3 0,05 ± 0,014 0,02
The between day to day variation is the square root of the difference of between groups and the within group variation divided by the
number of replicates and divided by the average of the measurements
 
 
x
MS
u
within
r =
x
n
MSMS
u
withinbetween
ip
−
=
negligibleum =
222
. mipr uuukcU ++=
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Day 1 Day 2 
ratio 1507/hmg % ratio 1507/hmg %
0,46 0,48
0,46 0,49
0,41 0,43
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
Sample 2 3 1,330797735 0,443599245 0,001041
Sample 4 3 1,395147965 0,465049322 0,000746
0,454324283
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 0,000690159 1 0,000690159 0,772685 0,429024 7,708647
Within Groups 0,003572783 4 0,000893196
Total 0,004262941 5
repeatability 6,6%
Method repeatability is the square of the within group MS divided by the average of the study
Between day variation 1,8%
measurement uncertainty exp
uncertainty for 3 duplicates on 2 days 4,0% 8,0%
uncertainty of the calibrant measurement uncertainty
negligible 0,018
expanded U rounded
Sample 2 0,4 ± 0,04 0,1
Sample 4 0,5 ± 0,04 0,1
sample 2-4 0,5 ± 0,04 0,1
The between day to day variation is the square root of the difference of between groups and the within group variation divided by the
number of replicates and divided by the average of the measurements
 
 
 
CCQM-P113 study final report 
 
39 
Lab 8 
 
Unknown 1 Unknown 2
U1 0,04 U4 0,60
Day 1 U2 0,05 U5 0,48
U3 0,04 U6 0,43
U7 0,03 U10 0,51
Day 2 U8 0,05 U11 0,44
U9 0,04 U12 0,49
Mean (%) 0,04 0,49
S.D 0,01 0,06
C.V(%) 17,16% 12,52%
IRMM Expanded Uncertainty(Ucrm) 0,014 0,14
IRMM Coverage factor; k (95%) 2 2
Std. Uncertainty (u) 0,0076449 0,074423
(SD/root n) n= 6
u_rel (%) 18,42 15,05
(std.U/mean x 100)
Degree of freedom 5,00 5,00
Coverage factor; k (95%) 2,57 2,57
Expanded Uncertainty(U) 0,02 0,19
(std.U x k)
U-rel (%) 47,34% 38,68%
(exp.U/mean x 100)
 
 
 
 
 
 
 
 
 
 
 
 
Lab 9 
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1507 hmg ratio U Uexp
1507/hmg
(cp) (cp) % (cp/cp) % (cp/cp) % (cp/cp)
U1 15 9751 0,15 0,05 0,10
Sample 1 U2 13 12186 0,11 0,04 0,08
U3 16 10015 0,16 0,05 0,10
U4 115 10813 1,06 0,25 0,50
Sample 2 U5 118 11046 1,07 0,25 0,51
U6 110 10370 1,06 0,26 0,52
U7 12 12805 0,09 0,03 0,04
Sample 3 U8 12 11974 0,10 0,04 0,04
U9 11 13028 0,08 0,03 0,02
U10 116 11112 1,04 0,14 0,29
Sample 4 U11 102 9104 1,12 0,20 0,41
U12 109 11140 0,98 0,17 0,35
average number of copies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lab 10 
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Sample 1 (U1-3, U7-9) 
Relative cp target/cp reference = 0.21 + 0.04 
 
Source of uncertainty Typical 
values 
Standard 
uncertainty 
Degree 
of 
freedom 
Type of 
uncertainty 
Regression from the 
calibration curve 
(reference) (copies 
number) 
4.39 0.139 3 A 
Regression from the 
calibration curve (target) 
(copies number) 
3.7 0.219 3 A 
Preparing calibration 
curve 
1 0.07 large B 
Pipetting on to plats 1 0.004 large B 
Precision 1 0.049 5 A 
 
          
u
c
  =  0.02  
U  =   0.04, k=2 
 
Sample 1 (U4-6, U10-12) 
Relative cp target/cp reference = 0.54 + 0.28 
 u
c
  =  0.14 
U  =   0.28, k=2 
 
 
 
 
 
 
 
 
 
Lab 11 
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%
1507 hmg ratio
1507/hmg U%(K=2) 
U1 3 4690 0,06 0,0411 66 sample 1 0,027004
U2 2 5199 0,03
U3 1 4308 0,03
U4 15 4483 0,34 0,3010 22 sample 2 0,066367
U5 11 4292 0,25
U6 12 4015 0,31
%
1507 hmg ratio
1507/hmg U%(K=2) 
U7 2,0 3629,04 0,06 0,06 51 sample 3 0,02857
U8 3,8 4768,11 0,08
U9 1,9 5997,76 0,03
U10 9,0 1599,00 0,56 0,41 32 sample 4 0,132089
U11 14,6 4728,71 0,31
U12 13,5 3650,78 0,37
average number of copies
average number of copies
 
 
Lab 12 
 
Sample 1 (U1-U3) 
% Relative cp target/cp reference = 0.22 + 0.03 (k=2)  
 Sample 2 (U7-U9)  
% Relative cp target/cp reference = 0.20 + 0.02 (k=2)  
 Sample 3 (U4-U6)  
% Relative cp target/cp reference = 0.34 + 0.06 (k=2)  
 Sample 4 (U10-U12)  
% Relative cp target/cp reference = 0.74 + 0.13 (k=2) 
 
Lab 13 (uncertainty calculation not yet received) 
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Lab 14 
 
Uncertainty estimates values for P113.  The estimates are based on standard error of the mean and the 
uncertainty of the calibrant supplied by IRMM. 
 
Sample1 Sample 3 
    
Combined 1,3 
   
0.037 0.063       
0.043 0.027       
0.057 0.037       
     
Copy Fraction Relative (%) 
 
0.046 0.042  Mean 0.044    
0.010 0.019  SD 0.014 32  
    
 
    
   
u precision SE of the mean 0.00559 13  
   
u calibrant Mean * 7% 0.00307 7  
   
 u combined 0.00638 15  
   
DF = 5, 
k=2.57 U95 0.016 37  
         
Sample 2 Sample 4   
  
Combined 2,4 
   
0.455 0.396       
0.459 0.441       
0.473 0.426       
     
Copy Fraction Relative (%) 
 
0.462 0.421  Mean 0.442    
0.010 0.023  SD 0.028 6  
    
 
    
   
u precision SE of the mean 0.01130 3  
   
u calibrant Mean * 7% 0.03091 7  
   
 u combined 0.03291 7  
   
DF = 5, 
k=2.57 U95 0.085 19  
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Abstract 
The provision of traceable standards to the biological community is an area of active research in 
many NMIs. The quantification of the relative amount of DNA sequences extracted from a biological 
tissue remains a complex analytical procedure and relies on the availability of such standards. Real-
time PCR is currently the most applied measurement method to identify and quantify DNA sequences. 
Several NMIs were able to demonstrate their ability to use this technology to quantify a defined 
plasmid DNA using the same plasmid DNA as a calibrant (CCQM-P44 (1&2) and CCQM KC-61). The 
same measurement method was used to quantify genomic DNA extracted from a plant tissue and 
calibrated by a genomic DNA solution extracted from the same plant material (CCQM-P60). In a later 
study, the importance of a reliable DNA extraction method became apparent. The analytical 
procedure was more complex in CCQM-P60 compared to KC61, as it included a DNA extraction step. 
However, both studies were performed using matching calibrants for which a reference value had 
been assigned. 
The goal of this pilot study was to demonstrate the ability to quantify DNA sequences present in a 
biological tissue using an independent calibration system. The quantification should ideally be 
performed by quantitative real-time PCR (QRT-PCR), but other methods not relying on the efficiency 
of thermal amplification such as digital PCR could also be applied. 
The methodology requires extraction and purification of genomic DNA and accurate detection and 
quantification of the relative amount of two defined DNA sequences in the extracted genomic DNA.  
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